Gastroesophageal Reflux Disease Devices Market by Product Type (Diagnostic Devices, Esophagoscopes & Gastroscopes, Fundoplication Devices), Procedure Type (Diagnostic Procedures, Fundoplication Procedures, Magnetic Sphincter Augmentation), Surgery Type, D

Gastroesophageal Reflux Disease Devices Market by Product Type (Diagnostic Devices, Esophagoscopes & Gastroscopes, Fundoplication Devices), Procedure Type (Diagnostic Procedures, Fundoplication Procedures, Magnetic Sphincter Augmentation), Surgery Type, Device Type, Dosage Form, Route of Administration, End-User - Global Forecast 2024-2030

The Gastroesophageal Reflux Disease Devices Market size was estimated at USD 5.85 billion in 2023 and expected to reach USD 6.65 billion in 2024, at a CAGR 13.66% to reach USD 14.35 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Gastroesophageal Reflux Disease Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Gastroesophageal Reflux Disease Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Gastroesophageal Reflux Disease Devices Market, highlighting leading vendors and their innovative profiles. These include Addex Pharmaceuticals Ltd., Aros Pharma ApS, AstraZeneca PLC, C. R. Bard, Inc., Eisai Co., Ltd., EndoGastric Solutions, Inc., Frost & Sullivan Inc., Johnson & Johnson Services, Inc., KARL STORZ SE & Co. KG, MediGus Ltd., Olympus Corporation, PENTAX Europe GmbH, Pfizer Inc., Takeda Pharmaceutical Company Limited, and The Procter & Gamble Company.

Market Segmentation & Coverage



This research report categorizes the Gastroesophageal Reflux Disease Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product Type
Diagnostic Devices
Esophagoscopes & Gastroscopes
Fundoplication Devices
Manometry System
PH Monitoring System
Radiofrequency Ablation Devices
Sphincter Augmentation Devices
Treatment Devices
Ultrasonic Surgical Endostapler
Procedure Type
Diagnostic Procedures
Fundoplication Procedures
Magnetic Sphincter Augmentation
Radiofrequency Thermal Ablation
Surgery Type
Invasive
Linx Reflux Management

Medigus Ultrasonic Surgical Endostapler
Non-Invasive
Endocinch Endolumminal Gastroplication

Endoscopic Plicator System

EsophyX

Plexiglas Poly-Methyl-Methacrylate Microspheres

Stretta
Device Type
Bravo Reflux Testing System
Digitrapper reflux testing system
LINX Management System
MUSE –Medigus Ultrasonic Surgical Endostapler
Stretta Therapy
Dosage Form
Liquid
Solid
Route of Administration
Oral
Parenteral
End-User
Government
Hospitals
Medical Practitioners
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Gastroesophageal Reflux Disease Devices Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Gastroesophageal Reflux Disease Devices Market?
3. What are the technology trends and regulatory frameworks in the Gastroesophageal Reflux Disease Devices Market?
4. What is the market share of the leading vendors in the Gastroesophageal Reflux Disease Devices Market?
5. Which modes and strategic moves are suitable for entering the Gastroesophageal Reflux Disease Devices Market?

Note: PDF & Excel + Online Access - 1 Year